Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Revenue Recognition

Revenue Recognition

posted on May 02, 2008 07:35PM

I finally got around to reading more of the 10Q. This may have already been posted but it's new to me. It appears that it's not the actual revenue receipts that are recognized in the 10Q.



From page 8 of 10Q:

Revenue from technology license agreements is recognized at the time we enter into a contract and provide the customer with the licensed technology. At this point, we have performed all of our obligations under contract, the rights to our technology have been transferred and no significant performance obligations remain.
Share
New Message
Please login to post a reply